We partner with a secure submission system to handle manuscript submissions.
Please note:
You will need an account for the submission system, which is separate to your Cambridge Core account. For login and submission support, please visit the
submission and support pages.
Please review this journal's author instructions, particularly the
preparing your materials
page, before submitting your manuscript.
Click Proceed to submission system to continue to our partner's website.
To save this undefined to your undefined account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your undefined account.
Find out more about saving content to .
To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Prenatal diagnosis of CHD is essential for counseling, perinatal management, and planning surgical strategies. Data from southern Chile are scarce.
Methods:
We conducted a retrospective, observational, descriptive study of all cases with a confirmed prenatal diagnosis of moderate or complex CHD at the Fetal Exploration Unit, Guillermo Grant Benavente Hospital, between January 2018 and March 2025. Maternales variables, fetal echocardiographic findings, genetic studies, and neonatal outcomes were analysed. Survival was estimated using Kaplan–Meier curves.
Results:
Eighty cases were analysed, one with complete atrioventricular block requiring pacemaker implantation and 79 with structural CHD. Male fetuses accounted for 63.8%. The most frequent entities were isolated or associated transposition of the great arteries (24.1%), hypoplastic left heart syndrome (16.5%), and coarctation of the aorta (10.1%). Twenty-one diagnostic combinations (26.6%) were documented, the most common being double-outlet right ventricle with transposition of the great arteries. Genetic testing was performed in 39 cases (48.8%), revealing chromosomal anomalies in 13 (16.3%). Maternal comorbidities were recorded in 27 pregnancies (33.8%), notably diabetes and hypothyroidism. Seventy percent of patients underwent neonatal cardiac surgery. Seventeen deaths (21.3%) occurred: one stillbirth and 16 postnatal deaths, of which 13 were neonatal. Overall survival at follow-up was 78.8%. Kaplan–Meier analysis showed a marked drop in the first month of life, stabilising thereafter at ∼81%.
Conclusions:
Findings highlight a high prevalence of critical lesions, a relevant proportion of chromosomal abnormalities, and a notable association with maternal hypothyroidism. Survival reflects advances in prenatal diagnosis and neonatal cardiac surgery, although challenges remain for non-surgical cases.
Knowledge of one’s defect is fundamental in optimising outcomes in adults with CHD. We aimed to assess factors associated with defect knowledge and how that knowledge may impact outcomes.
Methods:
We performed a cross-sectional cohort study of adults with CHDs aged 18–82 years with intervention between 1982 and 2003 at one of 11 US centres in the Pediatric Cardiac Care Consortium. Participants completed a survey in 2021–2023 regarding disease knowledge and various health and quality of life outcomes. After comparing participants’ self-identification of their defect to that recorded in the medical record, we identified demographic factors associated with correct identification and assessed the association of correct identification with outcomes.
Results:
Among 2747 respondents with one of the 18 types of CHDs on the survey, 2271 (83%) correctly identified their defect. Those who correctly identified their defect were more likely to be non-Hispanic White (84% correct), were <25 years of age (89%), have a higher level of education (86% for a bachelor’s degree and 87% for a graduate degree), and have higher household income (85% for income ≥$60,000). Those with severe two-ventricle disease were most likely to correctly identify their defect (88% correct); those with moderate disease were least likely (80% correct). Correct identification was associated with seeing a cardiologist in the last 5 years (74% vs. 63%, p < 0.001) but was mixed for other outcomes.
Conclusions:
Improving a person’s knowledge of their CHD may be an effective strategy for maintaining continuity of care.
Studies assessing the effect of preoperative iron supplementation in paediatric cardiac surgery are limited and yield conflicting data.
Objectives:
The study aimed to evaluate the effect of preoperative oral iron supplementation on allogeneic blood transfusion after cardiac surgery for acyanotic CHD.
Method:
This was a prospective, open-label, outcome assessor-blinded, randomised clinical trial performed in a large tertiary care centre in India. Children (haemoglobin <13 gm/dl) with acyanotic CHD were recruited for the study. Children in the intervention arm received colloidal iron (3 mg/kg), folic acid, and cyanocobalamin according to body weight for at least 7 days before cardiac surgery. The primary outcome was the amount of allogeneic blood transfusion, while secondary outcome measures were the duration of mechanical ventilation and ICU stay.
Results:
A total of eighty-six children (43 in each arm) completed the trials. A total of 43 children received iron supplementation for a minimum of 1 month. The haemoglobin level improved by 1.3 gm/dl immediately before the cardiac surgery in the intervention arm. The allogeneic blood transfusions (ml/kg) median (IQR) were significantly lower in the intervention group (5 (0–8) vs 10 (8–12); p < 0.01). Furthermore, total cumulative allogeneic blood transfusion was also significantly lower in the intervention arm (60 ml; (0–100) vs 100 ml; (70–140); p < 0.001). The duration of mechanical ventilation, ICU stay, and hospital stay was significantly lower in the intervention arm.
Conclusion:
Preoperative oral iron supplementation significantly reduces the need for allogeneic blood transfusion in children undergoing cardiac surgery for acyanotic heart disease.
Our study aimed to explore risk factors for medium–giant coronary artery aneurysms in children with Kawasaki disease.
Methods:
6,540 eligible children with Kawasaki disease who were diagnosed in Wuhan Children’s Hospital from January 2011 to December 2023 were retrospectively analysed. The clinical and laboratory data were compared between medium–giant group and non–medium–giant group.
Results:
A total of 6,540 patients with Kawasaki disease were included, and 162 (2.5%) developed medium–giant coronary artery aneurysms, of whom 56 (0.9%) were giant. Univariate analysis showed a statistically significant difference between the two groups in 22 variables (P< 0.05). The least absolute shrinkage and selection operator regression analysis revealed that intravenous immunoglobulin resistance, haemoglobin, platelet count, and albumin were the most significant risk factors for medium–giant coronary artery aneurysms. The result of binary logistic regression analysis showed that intravenous immunoglobulin resistance (OR = 6.474, 95%CI = 4.399 ∼ 9.528, P< 0.001), platelet count elevation (OR = 1.003, 95%CI = 1.002 ∼ 1.004, P< 0.001), and albumin reduction (OR = 0.912, 95%CI = 0.879 ∼ 0.946, P< 0.001) were independent risk factors affecting the occurrence of medium–giant coronary artery aneurysms, and the area under the curve of the regression model was 0.75, with a sensitivity of 62.3% and a specificity of 79.2%.
Conclusions:
Intravenous immunoglobulin resistance, platelet counts elevation, and albumin levels reduction may be significant predictors of medium–giant coronary artery aneurysms and can serve as a reference for early diagnosis of medium–giant coronary artery aneurysms.
Patients with hypoplastic left heart syndrome who develop a restrictive atrial septum prenatally have higher rates of postnatal mortality compared to those without atrial restriction. It is not understood whether the gestational age at which restriction becomes apparent echocardiographically impacts clinical outcomes.
Methods:
A single-centre, retrospective cohort study was performed, including 196 patients with hypoplastic left heart syndrome from 2008 to 2022. A restrictive atrial septum was diagnosed based on fetal echocardiographic findings of an intact atrial septum, antegrade:retrograde pulmonary vein Doppler velocity time integral ratio <3, and/or the presence of a decompressing vein. Patients were grouped as follows: 1. Without Restriction, 2. Early Restriction (<30 weeks’ gestation), and 3. Late Restriction (≥30 weeks’ gestation), based on the gestational age at which diagnostic criteria for restriction were met. Comparative postnatal overall survival and transplant-free survival analyses were performed using the Kaplan–Meier method.
Results:
Overall mortality rates were higher in the Early group (62%, n = 13) compared to the Late group (29%, n = 7) and the group without atrial restriction (40%). Similarly, transplant rates were higher in the Early group (23%) compared to the Late group (14%) and those without restriction (14%). Overall survival and transplant-free survival were not statistically different among the groups.
Conclusions:
While not statistically significant in this cohort with a small number of patients with atrial restriction, our data suggest that patients with hypoplastic left heart syndrome who meet diagnostic criteria for atrial restriction later in gestation may have outcomes more similar to those without atrial restriction.
In hypoplastic left heart syndrome with aortic atresia, the non-functional left ventricle may influence right ventricular performance. We evaluated serial changes in tricuspid and mitral valve diameters after the Norwood procedure and their relationship to right ventricular function.
Methods:
Of 150 patients who underwent the Norwood procedure (2001–2020), 47 died before total cavopulmonary connection. Of the 103 survivors, 76 with sufficient serial echocardiographic data were analysed (1,399 examinations). Tricuspid and mitral valve diameters were measured, and right ventricular function was assessed. Right ventricular dysfunction was defined as any degree of impairment. Mixed-effects models were used to account for repeated measures.
Results:
Median follow-up was 4.6 years (IQR 2.4–11.8). Right ventricular dysfunction was observed in 15.9% of examinations. Patients with right ventricular dysfunction had significantly larger tricuspid valve diameters than those with normal function (24.3 mm vs 23.4 mm, p = 0.006), whereas mitral valve diameters showed no significant difference (7.6 mm vs 7.1 mm, p = 0.120). The mitral/tricuspid ratio was similar between groups (0.320 versus 0.324, p = 0.340). Mixed-effects modelling showed that the tricuspid valve diameter remained 0.618 mm larger in the dysfunction group after adjusting for growth over time (p = 0.029). Tricuspid valve diameter differences emerged at the bidirectional cavopulmonary shunt stage and accelerated through Fontan completion (p < 0.001).
Conclusions:
In hypoplastic left heart syndrome with aortic atresia, right ventricular dysfunction is associated with progressive tricuspid valve enlargement but not with changes in the mitral/tricuspid ratio. While the stable ratio suggests proportional annular growth, a comprehensive volumetric assessment is needed to clarify ventricular-ventricular interactions.
To examine the accuracy of pulse oximetry in neonates by race and ethnicity.
Study Design:
We performed a single-centre retrospective cross-sectional study in neonates aged ≤ 7 days at Children’s Healthcare of Atlanta in the neonatal and cardiac ICU between 2010 and 2022. Eligible patients had pulse oximetry with arterial oxygen saturation measurements taken within 10 minutes. We evaluated the mean saturation bias, accuracy root mean square, and the frequency of occult hypoxaemia by race and ethnicity.
Results:
Of 1645 infants, there were 639 non-Hispanic Black infants (38.8%), 651 non-Hispanic White infants (39.6%), and 215 Hispanic infants (13.1%). The majority had no CHD (71.4%), required respiratory support (81.1%), and had oxygen saturation levels = > 90% (87.6%). The mean pulse oximetry and arterial oxygen measurement time difference was 0.8 minutes. The mean bias and accuracy root mean square were 8.7% and 13.7%, respectively, with no significant difference between the groups (p = 0.91). Occult hypoxaemia was found in 20.5% of infants. Compared to White infants, there were no differences in likelihood of occult hypoxaemia for either Black (adjusted prevalence ratio 1.13 (0.92–1.4), p = 0.24) or Hispanic (1.06 (0.77–1.45, p = 0.72) infants.
Conclusion:
There was not a systemic discrepancy in pulse oximetry between racial and ethnic groups as previously described in older children and adults. However, pulse oximetry significantly overestimated arterial oxygen saturation. Future prospective studies that objectively measure skin pigmentation may be able to overcome some of the limitations of our study.
Although acute type A aortic dissection (ATAAD) is a recognised complication of Turner syndrome, population-level data describing its prevalence and outcomes remain limited.
Methods:
We queried the National Inpatient Sample (2002–2020) and generated three groups: TS + ATAAD+, TS + ATAAD−, and TS−ATAAD+ in our retrospective observational cohort study. Primary outcomes were ATAAD hospital admission rate and in-hospital mortality; secondary outcomes included length of stay. Sampling weights were applied to all analyses.
Results:
A total of 51,426 Turner syndrome hospitalisations were identified. Median ages were 40 years (interquartile range 31–50) for TS + ATAAD+ and 32 years (interquartile range 9–49) for TS + ATAAD− (p < 0.001). Overall, 0.27% of Turner syndrome hospitalisations presented with ATAAD. Compared with TS + ATAAD−, those with ATAAD had higher mortality (13.1% vs 2.1%, p < 0.001) and longer length of stay (median 8 vs 3 days, p < 0.05). Rates of bicuspid aortic valve (34.3% vs 3.5%, p < 0.001), hypertension (46.0% vs 25.7%, p < 0.05), and complete heart block (14.6% vs 0.8%, p < 0.001) were also higher. Multivariable analysis showed bicuspid aortic valve (adjusted odds ratio 24.31, 95% CI 8.8–67.3) and age (adjusted odds ratio 1.02, 95% CI 1.01–1.04) predicted ATAAD. Compared with TS−ATAAD+ patients, those withTS + ATAAD+ were younger (40 vs 68 years, p < 0.001), while mortality, length of stay, hypertension, and bleeding rates were similar.
Conclusion:
ATAAD is highly lethal in patients with and without Turner syndrome. In Turner syndrome, ATAAD is associated with higher mortality, longer hospitalisation, and higher rates of bicuspid valve disease and hypertension.
Complex CHDs may impair organ development. One proposed mechanism is an altered relationship between blood flow, oxygen delivery, and subsequent organ growth. In this study, we examined whether fetal lung, intracranial, liver, and kidney volumes differ among fetuses with transposition of the great arteries with an intact ventricular septum, transposition of the great arteries with a ventricular septal defect, and healthy controls.
Methods:
Eleven fetuses with transposition of the great arteries (6 with a ventricular septal defect and 5 with an intact ventricular septum) and 22 healthy controls were scanned between 1 and 3 times at gestational age 27–38 weeks, using fetal MRI. We measured lung, total intracranial, liver, and kidney volumes and compared fetuses with and without transposition of the great arteries while subsequently correcting for ventricular septal defect/intact ventricular septum status, estimated fetal weight, and gestational age, using mixed effects regression analysis.
Results:
Fetuses with transposition of the great arteries+intact ventricular septum had significantly larger lung volumes compared to controls. After adjusting for estimated fetal weight and gestational age, median lung volume ratio (transposition of the great arteries+intact ventricular septum vs. controls) was 1.30 (95% CI: 1.08–1.57; p = 0.005). No difference was found in lung volume between fetuses with transposition of the great arteries+ventricular septal defect and controls. No significant differences in total intracranial, liver, and kidney volumes were found between transposition of the great arteries+ventricular septal defect, transposition of the great arteries+intact ventricular septum, and controls.
Conclusion:
In this preliminary study, late-gestation fetuses with transposition of the great arteries-intact ventricular septum had a 30% larger lung volume compared with both transposition of the great arteries-ventricular septal defect and healthy controls. Together with existing evidence of higher fetal pulmonary blood flow and increased oxygen saturation in transposition of the great arteries-intact ventricular septum, these findings support a potential link between blood flow, oxygen delivery, and organ growth.
Extrachromosomal circular DNAs are critical regulators of stress responses, immunity, and inflammation pathways. However, their role and underlying mechanisms in Kawasaki disease complicated by coronary artery aneurysm remain poorly understood.
Methods:
Whole blood samples from six children with Kawasaki disease, including three with coronary artery aneurysm group and three without coronary artery aneurysm (control group), were subjected to extrachromosomal circular DNA sequencing. Putative extrachromosomal circular DNAs were identified using Circle-Map. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed on genes associated with upregulated extrachromosomal circular DNAs, and an exploratory immune-signature profiling was performed using the single-sample gene set enrichment analysis algorithm.
Results:
We identified 4,790 differential extrachromosomal circular DNAs between the coronary artery aneurysm and control groups, of which 4,789 were upregulated in the CAA group. The extrachromosomal circular DNAs in the coronary artery aneurysm group were more concentrated and shorter in length than those in the control group. Upregulated extrachromosomal circular DNAs were mainly derived from autosomes, particularly chromosomes 3, 4, and 7. Functional enrichment analysis indicated that genes associated with upregulated extrachromosomal circular DNAs were mainly involved in response to stimulus-related terms and pathways, including chemokine signalling, cGMP-PKG signalling, and calcium signalling. Immune-signature analysis suggested that the coronary artery aneurysm group exhibited more specific immune responses, whereas the control group tended towards broader immune regulatory processes.
Conclusions:
Coronary artery aneurysm and control groups exhibited distinct extrachromosomal circular DNA profiles. These findings suggest that extrachromosomal circular DNA alterations are associated with coronary artery aneurysm in Kawasaki disease and may provide new insights into the molecular features underlying this condition.
Sirolimus is increasingly used for symptomatic or large cardiac rhabdomyoma, but the risk of recurrence remain unclear. We evaluated clinical response, tumour regression, recurrence, and safety in infants treated with sirolimus.
Methods:
This retrospective study included all infants with symptomatic or large cardiac rhabdomyoma treated with sirolimus between January 2022 and June 2025. Sirolimus was initiated at 1 mg/m2/day and titrated to maintain trough levels of 5–15 ng/mL. Serial echocardiography and electrocardiography monitored obstruction, cardiac function, arrhythmias, and tumour regression or recurrence.
Results:
For the 11 infants included, sirolimus was initiated at a mean age of 19.4 ± 8.9 days. Indications overlapped and included heart failure (n = 5), ventricular outflow tract obstruction (n = 4), clinically significant arrhythmias (n = 4), and the presence of a large tumour (n = 7). TSC1/TSC2 mutations were identified in 5 infants, and another 5 had extracardiac features of tuberous sclerosis complex. The mean tumour size reduced by 32% at 1 month and 77% at final follow-up, with complete disappearance in 64%. Arrhythmias resolved except in one infant with persistent congenital complete heart block present at baseline. The mean time to achieve a complete clinical response was 19.3 ± 3.98 days of sirolimus therapy. The mean duration of sirolimus therapy was 215 ± 103 days with a maximum of 385 days. Mild hypertriglyceridaemia (n = 2) was the only adverse effect, but it did not warrant discontinuation of sirolimus therapy. Three (27%) infants had tumour regrowth after treatment cessation; all responded promptly to re-initiation of sirolimus.
Conclusion:
Sirolimus is a safe and effective for symptomatic cardiac rhabdomyoma in infants, producing rapid clinical stabilisation and tumour regression. The optimal duration of therapy is uncertain, and the risk of tumour regrowth after cessation warrants longer follow-up.
Impaired muscle function, aerobic capacity, and fatigue are common in individuals with Fontan circulation. Knowledge regarding the effects of strength training in this population is limited. Therefore, the study aimed to investigate the effects of strength training on dynamic muscle function, aerobic capacity, and fatigue in adults with Fontan circulation compared to matched controls.
Methods:
In this pilot non-randomised controlled trial, nine patients with Fontan circulation (median age 28.9 years [IQR: 23.4–35.0], 44.4% women) and nine age- and sex-matched controls completed a 10-week strength training intervention. Dynamic muscle function was assessed through shoulder flexion, heel rise, elbow flexion, and knee extension tests. Aerobic capacity was evaluated using cardiopulmonary exercise testing, and fatigue using the questionnaire Multidimensional Fatigue Inventory. All assessments were conducted pre- and post-intervention. Within-group changes were analysed using the Wilcoxon signed rank test and between-group differences using the Mann–Whitney U test.
Results:
Patients showed improvements in all muscle function tests post-intervention (shoulder flexions 39.3% [IQR: 18.9–69.7], p = 0.008; heel rise 26.7% [IQR:17.5–58.1], p = 0.008; elbow flexions 57.1% [IQR: 50.0–173.8], p = 0.007; knee extensions 66.7% [24.3–92.9], p = 0.008). The improvements were at comparable levels to controls. Only controls reported reduced fatigue (–19.4% [IQR: –28.7, –10.5], p = 0.01), while patients showed no change (–5.9% [IQR: −25.5, 3.2], p = 0.1). Aerobic capacity remained unchanged. No severe adverse events occurred.
Conclusion:
Strength training is safe and improves dynamic muscle function in patients with Fontan circulation, with changes comparable to those of healthy controls. However, the effect of strength training on fatigue and aerobic capacity requires further investigation.
Case-based learning (CBL) is increasingly used across health professions education to promote clinical reasoning and professional competencies. In paediatric cardiology, rapid advances in diagnostics, interventions, and multidisciplinary care have intensified the need for educational approaches that integrate complex knowledge with real-world problem-solving.
Methods:
This narrative review outlines the theoretical foundations of CBL and examines the available literature on its implementation and effectiveness in medical education generally and paediatric cardiology specifically. Emerging applications of CBL, including simulation, virtual reality, and international collaborative case conferences, were also reviewed. Key design principles for effective CBL were explored, including case selection, alignment with competency-based curricula, faculty development, and assessment strategies.
Results:
Evidence suggests that CBL enhances clinical reasoning, knowledge integration, learner engagement, and the development of professional competencies. In paediatric cardiology, CBL supports the application of complex diagnostic and management principles within authentic clinical contexts. Emerging technology-enhanced approaches and international collaborative learning initiatives further expand opportunities for interactive and multidisciplinary education. However, challenges remain, including significant time and resource requirements, digital inequities, and the need for more rigorous evaluation of educational outcomes.
Conclusion:
Well-designed CBL appears to be a powerful educational strategy for preparing paediatric cardiology clinicians to deliver increasingly complex, team-based care. Future directions include greater integration of technology-enhanced learning, simulation-based approaches, and global educational networks to support trainees and practitioners across diverse practice settings while strengthening evidence for educational effectiveness.
The advanced practice registered nurse-led home monitoring programme has served as an early warning system for the fragile population of single ventricle infants discharged home between their staged interventions. However, patterns of care by the home monitoring team have not been studied.
Methods:
This retrospective, single-centre review of patients from 2010 to 2020 1) described patient characteristics and significant interstage events and 2) identified themes and patterns of care utilised by the advanced practice registered nurse and registered dietitian through review of communication in the electronic medical record.
Results:
The inclusion criteria were met by 334 patients. Of these, 55% underwent a Stage I Norwood as their initial intervention. Ten percent had a patent ductus arteriosus stent in the cardiac catheterisation lab, 79% of which occurred 2019 to 2020. Interstage mortality was 4.5%. Sixty-three percent of patients had at least one unplanned admission, while 26% of patients had an early cardiac catheterisation. Three themes were identified in provider-patient encounters: Clinical Management, Care Escalation, and Care Coordination, with two levels of care, standard and advanced. Most encounters (83%) were designated standard level of care. Encounters that required use of an interpreter (n = 204) took twice as long (p < .001).
Conclusions:
The home monitoring programme supports fragile infants during the interstage period at home. Using the newly developed Patterns of Care framework, most encounters were assessed to be “standard level of care.” Encounters utilising an interpreter due to caregiver’s limited English proficiency required significantly more time.
Atrial septal defect is a common CHD, and transcatheter closure is now the gold standard treatment. In an atrial septal defect, left-to-right shunting increases pulmonary blood flow. This study aimed to evaluate early changes in pulmonary artery, pulmonary vein, and inferior vena cava flow parameters following transcatheter closure of an atrial septal defect.
Materials and methods:
This retrospective study included 31 paediatric patients with haemodynamically significant atrial septal defect (Qp/Qs ≥ 1.5) who underwent transcatheter closure between January 2023 and June 2024. Comprehensive echocardiography was performed 24 hours before and after the procedure. Pulmonary artery and pulmonary vein maximum and mean pressure gradients, velocities, velocity–time integrals, inferior vena cava maximum and minimum diameters, and the inferior vena cava collapsibility index were analysed at both time points using standard transthoracic echocardiographic techniques.
Results:
When the data obtained were evaluated, it was observed that pulmonary artery maximum-mean pressure gradient (p < 0.001), pulmonary artery maximum-mean velocity (p < 0.001), pulmonary artery velocity–time integral (p < 0.001), pulmonary vein maximum pressure gradient (p < 0.001), pulmonary vein mean pressure gradient (p < 0.05), inferior vena cava maximum and minimum diameters (p < 0.001) and inferior vena cava collapsibility index (p < 0.05) decreased statistically significantly after transcatheter closure compared to before.
Conclusion:
The duration of remodelling in both the right and left atrial structures following transcatheter atrial septal defect closure depends on the extent of early changes in flow parameters. Our findings suggest that the inferior vena cava collapsibility index may serve as a simple, non-invasive indicator for closure criteria in future studies.
Pulmonary arteriovenous malformations (PAVMs) are a recognised cause of progressive cyanosis following bidirectional superior cavopulmonary anastomosis (BDG). The role of antegrade pulmonary blood flow (APBF) in preventing PAVM formation remains controversial. While preserved APBF may improve oxygen saturation and pulmonary artery growth, its protective effect against PAVMs is uncertain. Increasing evidence suggests that exclusion of hepatic venous blood from the pulmonary circulation, rather than absence of pulsatile flow, may be the primary mechanism underlying PAVM development. Therefore, management of APBF after BDG should be individualized.
Methods:
This retrospective observational study included children with univentricular physiology who underwent BDG before 4 years of age with a minimum follow-up of two years. Patients were divided into two groups based on the presence or interruption of APBF. Clinical data, oxygen saturation, echocardiographic findings, pulmonary artery dimensions, and imaging evidence of PAVMs were analysed using computed tomography angiography and/or cardiac catheterisation. Outcomes were compared between groups.
Results:
Sixty patients were included. PAVMs occurred in 26.7% of patients with interrupted APBF and 23.3% with preserved APBF (p = 0.766). Oxygen saturation was higher in the preserved APBF group but not statistically significant. Pulmonary artery dimensions and pressures were comparable, and all patients remained suitable for Fontan completion. Cyanosis was more frequent in the APBF-interrupted group.
Conclusions:
Preserved APBF improves oxygen saturation but does not reduce PAVM incidence. Hepatic venous exclusion appears to be the primary determinant of PAVM development, supporting individualized surgical decision-making.
Data on thromboembolism treatment and outcomes in children with cardiac disease are limited. We sought to characterise thromboembolism treatment and outcomes in paediatric patients with cardiac disease.
Methods:
A single-centre, retrospective cohort study of children, aged < 21 years, with cardiac disease admitted to a paediatric cardiac ICU from October 2020 to September 2024, diagnosed with acute symptomatic thromboembolism (radiologically confirmed first episode). We analysed demographics, thromboembolism characteristics, antithrombotic drug regimens, and outcomes (recurrent thromboembolism, clinically relevant bleeding).
Results:
Of 865 eligible patients, 75 (8.7%) developed acute symptomatic thromboembolism: 48 (64%) venous; 16 (21.3%) arterial; 9 (12%) intracardiac; 2 (2.7%) venous+arterial. Of 50 patients with venous or venous+arterial, 33 (66%) received anticoagulation in the acute phase. Of 18 patients with arterial or arterial+venous, 12 (66.7%) received anticoagulation in the acute phase. Recurrent thromboembolism occurred in 28 (37.3%) patients, more likely among single ventricle vs. biventricular physiology [OR 3.2 (95% CI 1.1 to 9.4), p = 0.04]. Clinically relevant bleeding occurred in 10 (13.3%) patients, mostly with concomitant antithrombotics (anticoagulation + antiplatelet) vs. monotherapy [6 (9.2%) vs. 4 (40.0%), p = 0.02] in the subacute phase of treatment. The literature review revealed limited data on treatment strategies.
Conclusion:
There is variation in the treatment strategy for thromboembolism in children with cardiac disease, with risk for thromboembolism, recurrent thromboembolism, and bleeding. Prospective multicentre studies are needed to extend preliminary findings on treatment strategies and risk factors.
The apical impulse palpation is a key component of cardiac physical examination, which offers insights into ventricular size and function. Its diagnostic accuracy in detecting cardiac enlargement in infants is unknown.
Methods:
This cross-sectional observational study was done in infants 1 month to 1 year of age visiting a tertiary care hospital. The apical impulse was palpated and marked in supine position and its location in terms of the intercostal space and distance from mid-sternal line was noted. Echocardiography was performed to assess cardiac chamber enlargement. Z score of echo parameters was calculated. z score > 2 was considered to be an enlarged cardiac chamber. The diagnostic accuracy of a displaced apical impulse in detecting ventricular enlargement was evaluated using echocardiography as the reference standard.
Results:
309 infants were enrolled in the study. 22 % of the study subjects had a structurally normal heart. A displaced apical impulse had a diagnostic accuracy of 71.5%. Using another definition to define a displaced apical impulse, namely, horizontal displacement of > 4 cm from the mid-sternal line (regardless of the level of intercostal space), increased the diagnostic accuracy to 79.0 % with sensitivity and specificity of 76.4% and 81.1 %, respectively.
Conclusion:
Horizontal displacement of the apical impulse 4 cm or more from the mid-sternal line (regardless of the level of intercostal space) is a simple and fairly accurate method to identify left ventricular enlargement in infants.
There has been a growing clinical application of ketamine for procedural sedation. This study aimed to determine its hemodynamic effects when utilized in patients in the pediatric cardiac intensive care unit.
Methods:
In this single-center, retrospective study, patients who were admitted to the pediatric cardiac intensive care unit and received a single dose of intravenous ketamine were studied. Patients were monitored utilizing high-fidelity physiologic data. Variables of interest for the study included: heart rate, arterial saturation, respiratory rate, mean arterial blood pressure, central venous pressure, and renal near infrared spectroscopy These variables of interest were obtained 30 min prior to the administration of ketamine, through 30 min after, serving as the comparison arm. Secondary aims included unexpected apnea, need for a fluid bolus, vasoactive bolus, or cardiopulmonary resuscitation.
Results:
A total of 45 administrations of intravenous ketamine were included. Average dose was 0.8 mg/kg per dose. Average age was 8.1 months. After administration of ketamine, there was a statistically significant increase in heart rate, arterial saturation, renal near infrared spectroscopy and central venous pressure and a statistically significant decrease in respiratory rate and mean arterial blood pressure. No cardiopulmonary resuscitation or bolus vasoactive was required after ketamine administration.
Conclusion:
Intravenous ketamine dosed from 0.5 mg/kg to 1 mg/kg per dose in the pediatric cardiac intensive care unit appears safe and is associated with minimal hemodynamic change, apnea, or hemodynamic collapse. This represents the first data related to a single dose of ketamine’s effect captured with a 1-s temporal resolution.
Children with ventricular septal defects experience chronic left-to-right shunting, resulting in ventricular volume overload and alterations in myocardial electrical properties. Data on ventricular electrical remodelling following closure, particularly regarding closure technique, remain limited.
Objectıve:
To evaluate ventricular depolarisation and repolarisation indices in children with isolated ventricular septal defects before and after closure and to compare the outcomes of surgical and transcatheter approaches.
Methods:
This retrospective, single-centre study included 58 children aged 4–18 months who underwent isolated ventricular septal defect closure (transcatheter, n = 25; surgical, n = 33) and 40 age- and sex-matched healthy controls. Standard 12-lead electrocardiograms recorded before the procedure and at six months after closure were analysed. Multiple ventricular depolarisation and repolarisation indices were assessed.
Results:
Before closure, children with ventricular septal defects demonstrated significant abnormalities in ventricular depolarisation and repolarisation indices compared with healthy controls (all p < 0.05). Following closure, most repolarisation indices improved in both groups. Improvement was more pronounced after transcatheter closure, whereas QT interval and QT dispersion did not significantly improve following surgical closure. At the six-month follow-up, QRS duration remained significantly longer in both interventions than in controls.
Conclusion:
Children with isolated ventricular septal defects demonstrate subclinical alterations in ventricular depolarisation and repolarisation. Defect closure is associated with substantial improvement in ventricular repolarisation; however, depolarisation abnormalities may persist during mid-term follow-up irrespective of closure technique.